Prompteneering. Open the library →

Clinical Trial Diversity and Inclusion Plan Designer for FDA Draft Guidance Compliance for Launch Readiness for Cross-Functional Rollout

Designs a comprehensive Diversity and Inclusion Plan for a Phase III clinical trial aligned to FDA's 2022 Draft Guidance on Diversity Action Plans, specifying enrollment targets, site selection criteria, and retention strategies by demographic group.

Open this agent in the library →

More Clinical Operations & Site Management agents

All Clinical Operations & Site Management agents · All Clinical Trials & Regulatory Affairs agents